Related references
Note: Only part of the references are listed.Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience
Sylwia Jasinski et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports
Julie Cayrol et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial
Karen L. Bride et al.
BLOOD (2016)
Sirolimus for Refractory Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review of the Treatment of Post-Transplant Autoimmune Hemolytic Anemia
Jeong A. Park et al.
TRANSFUSION MEDICINE REVIEWS (2016)
Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience
Maurizio Miano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Sirolimus as Maintenance Treatment in an Infant With Life-threatening Multiresistant Pure Red Cell Anemia/Autoimmune Hemolytic Anemia
Maurizio Miano et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2014)
Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
Ping Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor
Melissa A. Acquazzino et al.
PEDIATRIC TRANSPLANTATION (2013)
Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Share Paper
